XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current Assets:    
Cash and cash equivalents $ 270,814 $ 217,666
Restricted cash 524 523
Short-term investments 49,848 91,695
Accounts receivable, net 122,400 130,990
Inventory 254,461 228,732
Prepaid and other current assets 19,464 19,492
Total current assets 717,511 689,098
Property, plant and equipment, net 147 874
Long-term investments   1,275
Long-term inventory 91,792 163,620
Operating lease right-of-use asset 8,510 9,074
Other long-term assets 1,395 458
Intangible asset, net 19,676 21,780
TOTAL ASSETS 839,031 886,179
Current Liabilities:    
Accounts payable 53,362 64,602
Accrued expenses and other current liabilities 211,304 192,678
Current deferred revenue 2,025 2,199
Total current liabilities 266,691 259,479
Long-Term Liabilities:    
Long-term deferred revenue 2,949 13,147
Long-term operating lease liability 8,970 10,015
Other long-term liabilities 7,273 8,205
Total liabilities 285,883 290,846
Commitments and contingencies (Note 5)
Stockholders’ Equity:    
Common stock, GBP 0.50 par, unlimited authorized; 417,744,958 shares issued, 408,551,020 shares outstanding as of September 30,2023; 412,333,087 shares issued, 404,346,256 shares outstanding as of December 31, 2022 302,318 299,002
Additional paid-in capital 1,895,155 1,885,352
Treasury stock; 9,193,938 shares as of September 30, 2023; 7,986,831 shares as of December 31, 2022 (63,743) (61,770)
Accumulated deficit (1,580,582) (1,527,251)
Total stockholders’ equity 553,148 595,333
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 839,031 $ 886,179